Why do intestinal epithelial cells express MHC class II?
Why do intestinal epithelial cells express MHC class II?
复制标题
DOI:
10.1111/imm.13270
复制
发表时间:
2021-04
期刊:
影响因子:
6.4
通讯作者:
Maloy KJ
中科院分区:
文献类型:
--
作者:
Heuberger C;Pott J;Maloy KJ
Intestinal epithelial cells (IECs) constitute the border between the vast antigen load present in the intestinal lumen and the mucosal immune compartment. Their ability to express antigen processing and presentation machinery evokes the question whether IECs function as non‐conventional antigen‐presenting cells. Major histocompatibility complex (MHC) class II expression by non‐haematopoietic cells, such as IECs, is tightly regulated by the class II transactivator (CIITA) and is classically induced by IFN‐γ. As MHC class II expression by IECs is upregulated under inflammatory conditions, it has been proposed to activate effector CD4+ T (Teff) cells. However, other studies have reported contradictory results and instead suggested a suppressive role of antigen presentation by IECs, through regulatory T (Treg)‐cell activation. Recent studies investigating the role of MHC class II + exosomes released by IECs also reported conflicting findings of either immune enhancing or immunosuppressive activities. Moreover, in addition to modulating inflammatory responses, recent findings suggest that MHC class II expression by intestinal stem cells may elicit crosstalk that promotes epithelial renewal. A more complete understanding of the different consequences of IEC MHC class II antigen presentation will guide future efforts to modulate this pathway to selectively invoke protective immunity while maintaining tolerance to beneficial antigens. Intestinal epithelial cells (IECs) can express MHC class II molecules both at steady state and during inflammation, suggesting that they may shape local CD4+ T‐cell responses towards intestinal antigens. However, the outcome of MHC class II antigen presentation by IECs appears context dependent, resulting in either enhanced pro‐inflammatory responses or in tolerogenic regulatory T‐cell activation. A better understanding of the functions of MHC class II expression by IECs may allow the design of new therapies for intestinal diseases, which either enhance protective immunity or ameliorate harmful inflammation.
登录
查看更多内容
DOI:
10.1038/nri3405
发表时间:
2013-04
期刊:
Nature reviews. Immunology
影响因子:
--
作者:
通讯作者:
--
影响因子:
64.8
作者:
Gerbe F;Sidot E;Smyth DJ;Ohmoto M;Matsumoto I;Dardalhon V;Cesses P;Garnier L;Pouzolles M;Brulin B;Bruschi M;Harcus Y;Zimmermann VS;Taylor N;Maizels RM;Jay P
通讯作者:
Jay P
影响因子:
2.7
作者:
Feng, Xiao Ming;Chen, Xiao Li;Han, Zhong Chao
通讯作者:
Han, Zhong Chao
影响因子:
24.5
作者:
FAIS, S;MAIURI, L;AURICCHIO, S
通讯作者:
AURICCHIO, S
DOI:
10.1038/nri3212
发表时间:
2012-05-11
期刊:
Nature reviews. Immunology
影响因子:
--
作者:
通讯作者:
--